Testing the Addition of an Anti-cancer Drug, Lenalidomide, to the Usual Combination Chemotherapy Treatment ("EPOCH") for Adult T-Cell Leukemia-Lymphoma (ATLL)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
OHSU Knight Cancer Institute
Dana-Farber Cancer Institute
Dana-Farber Cancer Institute
Therapeutic Advances in Childhood Leukemia Consortium
University of Washington
SWOG Cancer Research Network
Children's Oncology Group
University of Utah
National Cancer Institute (NCI)
University of California, San Francisco
Northwestern University
National Institutes of Health Clinical Center (CC)
Fred Hutchinson Cancer Center